Unknown

Dataset Information

0

Low-dose endotoxin inhalation in healthy volunteers--a challenge model for early clinical drug development.


ABSTRACT: Inhalation of endotoxin (LPS) induces a predominantly neutrophilic airway inflammation and has been used as model to test the anti-inflammatory activity of novel drugs. In the past, a dose exceeding 15-50 ?g was generally needed to induce a sufficient inflammatory response. For human studies, regulatory authorities in some countries now request the use of GMP-grade LPS, which is of limited availability. It was therefore the aim of this study to test the effect and reproducibility of a low-dose LPS challenge (20,000 E.U.; 2 ?g) using a flow- and volume-controlled inhalation technique to increase LPS deposition.Two to four weeks after a baseline sputum induction, 12 non-smoking healthy volunteers inhaled LPS on three occasions, separated by at least 4 weeks. To modulate the inflammatory effect of LPS, a 5-day PDE4 inhibitor (Roflumilast) treatment preceded the last challenge. Six hours after each LPS inhalation, sputum induction was performed.The low-dose LPS inhalation was well tolerated and increased the mean percentage of sputum neutrophils from 25% to 72%. After the second LPS challenge, 62% neutrophils and an increased percentage of monocytes were observed. The LPS induced influx of neutrophils and the cumulative inflammatory response compared with baseline were reproducible. Treatment with Roflumilast for 5 days did not have a significant effect on sputum composition.The controlled inhalation of 2 ?g GMP-grade LPS is sufficient to induce a significant neutrophilic airway inflammation in healthy volunteers. Repeated low-dose LPS challenges potentially result in a small shift of the neutrophil/monocyte ratio; however, the cumulative response is reproducible, enabling the use of this model for "proof-of-concept" studies for anti-inflammatory compounds during early drug development.

SUBMITTER: Janssen O 

PROVIDER: S-EPMC3635929 | biostudies-literature | 2013 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Low-dose endotoxin inhalation in healthy volunteers--a challenge model for early clinical drug development.

Janssen Ole O   Schaumann Frank F   Holz Olaf O   Lavae-Mokhtari Bianca B   Welker Lutz L   Winkler Carla C   Biller Heike H   Krug Norbert N   Hohlfeld Jens M JM  

BMC pulmonary medicine 20130328


<h4>Background</h4>Inhalation of endotoxin (LPS) induces a predominantly neutrophilic airway inflammation and has been used as model to test the anti-inflammatory activity of novel drugs. In the past, a dose exceeding 15-50 μg was generally needed to induce a sufficient inflammatory response. For human studies, regulatory authorities in some countries now request the use of GMP-grade LPS, which is of limited availability. It was therefore the aim of this study to test the effect and reproducibil  ...[more]

Similar Datasets

| S-EPMC5363753 | biostudies-literature
| S-EPMC4323893 | biostudies-literature
| S-EPMC6951451 | biostudies-literature
| S-EPMC6977803 | biostudies-literature
| S-EPMC4420691 | biostudies-literature
| S-EPMC9290695 | biostudies-literature